Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT₃ receptor

References

• Boess FG, Steward LJ, Steele JA, Liu D, Reid J, Glencorse TA, Martin IL. Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology 1997; 36: 637–647
   PubMedGoogle Scholar
• Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, Sixma TK. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001; 411: 269–276
   PubMed Web of Science ®Google Scholar
• Celie PH, van Rossum-Fikkert SE, van Dijk WJ, Brejc K, Smit AB, Sixma TK. Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 2004; 41: 907–914
   PubMed Web of Science ®Google Scholar
• Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745–2752
   PubMed Web of Science ®Google Scholar
• Cromer BA, Morton CJ, Parker MW. Anxiety over GABAA receptor structure relieved by AChBP. Trends Biochem Sci 2002; 27: 280–287
   PubMed Web of Science ®Google Scholar
• Hargreaves AC, Gunthorpe MJ, Taylor CW, Lummis SC. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L- type Ca2 +  channels. Mol Pharmacol 1996; 50: 1284–1294
   PubMed Web of Science ®Google Scholar
• Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 1985; 82: 488–492
   PubMed Web of Science ®Google Scholar
• Le Novere N, Grutter T, Changeux JP. Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2 + -binding sites. Proc Natl Acad Sci USA 2002; 99: 3210–3215
   PubMed Web of Science ®Google Scholar
• Lummis SC, Sepulveda MI, Kilpatrick GJ, Baker J. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells. Eur J Pharmacol 1993; 243: 7–11
   PubMed Web of Science ®Google Scholar
• Maksay G, Bikadi Z, Simonyi M. Binding interactions of antagonists with 5-hydroxytryptamine3A receptor models. J Recept Signal Transduct Res 2003; 23: 255–270
   PubMed Web of Science ®Google Scholar
• Price KL, Lummis SC. The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor. J Biol Chem 2004; 279: 23294–23301
   PubMedGoogle Scholar
• Price KL, Lummis SC. FlexStation examination of 5-HT3 receptor function using Ca2 + - and membrane potential-sensitive dyes: advantages and potential problems. J Neurosci Methods 2005; 149: 172–177
   Google Scholar
• Reeves DC, Lummis SC. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol Membr Biol 2002; 19: 11–26
   PubMed Web of Science ®Google Scholar
• Reeves DC, Sayed MF, Chau PL, Price KL, Lummis SC. Prediction of 5-HT3 receptor agonist-binding residues using homology modeling. Biophys J 2003; 84: 2338–2344
   PubMed Web of Science ®Google Scholar
• Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779–815
   PubMed Web of Science ®Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, New York 1989; 15,54–15,56
   Google Scholar
• Schapira M, Abagyan R, Totrov M. Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine. BMC Struct Biol 2002; 2: 1
   Google Scholar
• Sine SM, Quiram P, Papanikolaou F, Kreienkamp HJ, Taylor P. Conserved tyrosines in the alpha subunit of the nicotinic acetylcholine receptor stabilize quaternary ammonium groups of agonists and curariform antagonists. J Biol Chem 1994; 269: 8808–8816
   PubMedGoogle Scholar
• Spier AD, Lummis SC. The role of tryptophan residues in the 5-Hydroxytryptamine3 receptor ligand binding domain. J Biol Chem 2000; 275: 5620–5625
   PubMedGoogle Scholar
• Spier AD, Wotherspoon G, Nayak SV, Nichols RA, Priestley JV, Lummis SC. Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors. Mol Brain Res 1999; 67: 221–230
   Google Scholar
• Steward LJ, Boess FG, Steele JA, Liu D, Wong N, Martin IL. Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine3A receptor. Mol Pharmacol 2000; 57: 1249–1255
   Google Scholar
• Tairi AP, Hovius R, Pick H, Blasey H, Bernard A, Surprenant A, Lundstrom K, Vogel H. Ligand binding to the serotonin 5HT3 receptor studied with a novel fluorescent ligand. Biochemistry 1998; 37: 15850–15864
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Price KL, Reeves DC, Chan SL, Chau PL, Lummis SC. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. J Biol Chem 2005; 280: 20476–20482
   PubMed Web of Science ®Google Scholar
• Turchin A, Lawler JF, Jr. The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis. Biotechniques 1999; 26: 672–676
   PubMed Web of Science ®Google Scholar
• Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4Å resolution. J Mol Biol 2005; 346: 967–989
   PubMed Web of Science ®Google Scholar